Anti-PCSK9 Monoclonal Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Alizumab, Evolocumab); Application (Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Others) and Geography

Report Code: TIPRE00023268 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

The antibodies are proteins generated by the body's immune system in response to specific antigens such as bacteria, viruses, parasites, and others identified as foreign. Monoclonal antibodies are protein produced by the immune system that targets a particular antigen in the body. Monoclonal antibodies are used in immunotherapy such as for diagnostic and therapeutic purposes. PCSK9 is proprotein convertase subtilisin/Kexin type 9, a member of the subtilisin family of serine proteases. It binds to the LDL receptor (LDLR), promoting LDLR degradation, thus resulting in less LDL sequestration and increased LDL-C levels. Numerous clinical trials have been done to demonstrate the efficacy of monoclonal antibodies against PCSK9 for lowering LDL-C levels. The targeted inhibition of PCSK9 would promote LDL catabolism and, thus, allow reduction of LDL-C levels.

MARKET SCOPE

The "Global Anti-PCSK9 Monoclonal Antibody Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the anti-PCSK9 monoclonal antibody market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading anti-PCSK9 monoclonal antibody market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global anti-PCSK9 monoclonal antibody market is segmented into alizumab and evolocumab.
  •  On the basis of application, the market is bifurcated into hypercholesterolemia, atherosclerotic cardiovascular disease and others.

MARKET DYNAMICS

Drivers

  •  Increasing incidences of obesity globally, rising consumption of junk foods, and lack of regular exercise drive the anti-PCSK9 monoclonal antibody market.
  •  Rising R&D activities focusing on monoclonal antibodies against PCSK9 and technological advancements boost the market growth.
  •  Growing patients pool suffering from primary hypercholesterolemia and atherosclerotic cardiovascular disease fuel the market growth.

Restraints

  •  Availability of alternative treatment methods.
  •  High cost of monoclonal antibody.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The anti-PCSK9 monoclonal antibody market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the anti-PCSK9 monoclonal antibody market in these regions.

IMPACT OF COVID-19 ON ANTI-PCSK9 MONOCLONAL ANTIBODY MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The worldwide lockdown due to the pandemic has placed an economic burden on the healthcare sector. Therefore, research was limited, and researchers have to ensure the safety of trial participants, comply with good clinical practice (GCP), and minimize risks to trial integrity for the duration of the COVID-19 public health emergency. However, the market may witness growth in the future due to the companies rearranging their operations and recovering from the COVID-19 impact.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the anti-PCSK9 monoclonal antibody market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from anti-PCSK9 monoclonal antibody market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-PCSK9 monoclonal antibody in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the anti-PCSK9 monoclonal antibody market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Sanofi + Regeneron
  •  Amgen
  •  Creative Diagnostics
  •  Thermo Fisher Scientific
  •  Abnova
  •  Dr. Reddy's
  •  Merck
  •  GeneTex
  •  Novartis AG
  •  PerkinElmer

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-PCSK9 Monoclonal Antibody Market - By Type
1.3.2 Anti-PCSK9 Monoclonal Antibody Market - By Application
1.3.3 Anti-PCSK9 Monoclonal Antibody Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTI-PCSK9 MONOCLONAL ANTIBODY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTI-PCSK9 MONOCLONAL ANTIBODY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTI-PCSK9 MONOCLONAL ANTIBODY MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-PCSK9 MONOCLONAL ANTIBODY - GLOBAL MARKET OVERVIEW
6.2. ANTI-PCSK9 MONOCLONAL ANTIBODY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. ANTI-PCSK9 MONOCLONAL ANTIBODY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ALIZUMAB
7.3.1. Overview
7.3.2. Alizumab Market Forecast and Analysis
7.4. EVOLOCUMAB
7.4.1. Overview
7.4.2. Evolocumab Market Forecast and Analysis
8. ANTI-PCSK9 MONOCLONAL ANTIBODY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HYPERCHOLESTEROLEMIA
8.3.1. Overview
8.3.2. Hypercholesterolemia Market Forecast and Analysis
8.4. ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
8.4.1. Overview
8.4.2. Atherosclerotic Cardiovascular Disease Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. ANTI-PCSK9 MONOCLONAL ANTIBODY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anti-PCSK9 Monoclonal Antibody Market Overview
9.1.2 North America Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis
9.1.3 North America Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Type
9.1.4 North America Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Application
9.1.5 North America Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Anti-PCSK9 Monoclonal Antibody Market
9.1.5.1.1 Canada Anti-PCSK9 Monoclonal Antibody Market by Type
9.1.5.1.2 Canada Anti-PCSK9 Monoclonal Antibody Market by Application
9.1.5.2 Mexico Anti-PCSK9 Monoclonal Antibody Market
9.1.5.2.1 Mexico Anti-PCSK9 Monoclonal Antibody Market by Type
9.1.5.2.2 Mexico Anti-PCSK9 Monoclonal Antibody Market by Application
9.1.5.3 US Anti-PCSK9 Monoclonal Antibody Market
9.1.5.3.1 US Anti-PCSK9 Monoclonal Antibody Market by Type
9.1.5.3.2 US Anti-PCSK9 Monoclonal Antibody Market by Application
9.2. EUROPE
9.2.1 Europe Anti-PCSK9 Monoclonal Antibody Market Overview
9.2.2 Europe Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis
9.2.3 Europe Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Type
9.2.4 Europe Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Application
9.2.5 Europe Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anti-PCSK9 Monoclonal Antibody Market
9.2.5.1.1 Germany Anti-PCSK9 Monoclonal Antibody Market by Type
9.2.5.1.2 Germany Anti-PCSK9 Monoclonal Antibody Market by Application
9.2.5.2 France Anti-PCSK9 Monoclonal Antibody Market
9.2.5.2.1 France Anti-PCSK9 Monoclonal Antibody Market by Type
9.2.5.2.2 France Anti-PCSK9 Monoclonal Antibody Market by Application
9.2.5.3 Italy Anti-PCSK9 Monoclonal Antibody Market
9.2.5.3.1 Italy Anti-PCSK9 Monoclonal Antibody Market by Type
9.2.5.3.2 Italy Anti-PCSK9 Monoclonal Antibody Market by Application
9.2.5.4 Spain Anti-PCSK9 Monoclonal Antibody Market
9.2.5.4.1 Spain Anti-PCSK9 Monoclonal Antibody Market by Type
9.2.5.4.2 Spain Anti-PCSK9 Monoclonal Antibody Market by Application
9.2.5.5 United Kingdom Anti-PCSK9 Monoclonal Antibody Market
9.2.5.5.1 United Kingdom Anti-PCSK9 Monoclonal Antibody Market by Type
9.2.5.5.2 United Kingdom Anti-PCSK9 Monoclonal Antibody Market by Application
9.2.5.6 Rest of Europe Anti-PCSK9 Monoclonal Antibody Market
9.2.5.6.1 Rest of Europe Anti-PCSK9 Monoclonal Antibody Market by Type
9.2.5.6.2 Rest of Europe Anti-PCSK9 Monoclonal Antibody Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anti-PCSK9 Monoclonal Antibody Market Overview
9.3.2 Asia-Pacific Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis
9.3.3 Asia-Pacific Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anti-PCSK9 Monoclonal Antibody Market
9.3.5.1.1 Australia Anti-PCSK9 Monoclonal Antibody Market by Type
9.3.5.1.2 Australia Anti-PCSK9 Monoclonal Antibody Market by Application
9.3.5.2 China Anti-PCSK9 Monoclonal Antibody Market
9.3.5.2.1 China Anti-PCSK9 Monoclonal Antibody Market by Type
9.3.5.2.2 China Anti-PCSK9 Monoclonal Antibody Market by Application
9.3.5.3 India Anti-PCSK9 Monoclonal Antibody Market
9.3.5.3.1 India Anti-PCSK9 Monoclonal Antibody Market by Type
9.3.5.3.2 India Anti-PCSK9 Monoclonal Antibody Market by Application
9.3.5.4 Japan Anti-PCSK9 Monoclonal Antibody Market
9.3.5.4.1 Japan Anti-PCSK9 Monoclonal Antibody Market by Type
9.3.5.4.2 Japan Anti-PCSK9 Monoclonal Antibody Market by Application
9.3.5.5 South Korea Anti-PCSK9 Monoclonal Antibody Market
9.3.5.5.1 South Korea Anti-PCSK9 Monoclonal Antibody Market by Type
9.3.5.5.2 South Korea Anti-PCSK9 Monoclonal Antibody Market by Application
9.3.5.6 Rest of Asia-Pacific Anti-PCSK9 Monoclonal Antibody Market
9.3.5.6.1 Rest of Asia-Pacific Anti-PCSK9 Monoclonal Antibody Market by Type
9.3.5.6.2 Rest of Asia-Pacific Anti-PCSK9 Monoclonal Antibody Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anti-PCSK9 Monoclonal Antibody Market Overview
9.4.2 Middle East and Africa Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis
9.4.3 Middle East and Africa Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anti-PCSK9 Monoclonal Antibody Market
9.4.5.1.1 South Africa Anti-PCSK9 Monoclonal Antibody Market by Type
9.4.5.1.2 South Africa Anti-PCSK9 Monoclonal Antibody Market by Application
9.4.5.2 Saudi Arabia Anti-PCSK9 Monoclonal Antibody Market
9.4.5.2.1 Saudi Arabia Anti-PCSK9 Monoclonal Antibody Market by Type
9.4.5.2.2 Saudi Arabia Anti-PCSK9 Monoclonal Antibody Market by Application
9.4.5.3 U.A.E Anti-PCSK9 Monoclonal Antibody Market
9.4.5.3.1 U.A.E Anti-PCSK9 Monoclonal Antibody Market by Type
9.4.5.3.2 U.A.E Anti-PCSK9 Monoclonal Antibody Market by Application
9.4.5.4 Rest of Middle East and Africa Anti-PCSK9 Monoclonal Antibody Market
9.4.5.4.1 Rest of Middle East and Africa Anti-PCSK9 Monoclonal Antibody Market by Type
9.4.5.4.2 Rest of Middle East and Africa Anti-PCSK9 Monoclonal Antibody Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anti-PCSK9 Monoclonal Antibody Market Overview
9.5.2 South and Central America Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis
9.5.3 South and Central America Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Type
9.5.4 South and Central America Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Application
9.5.5 South and Central America Anti-PCSK9 Monoclonal Antibody Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anti-PCSK9 Monoclonal Antibody Market
9.5.5.1.1 Brazil Anti-PCSK9 Monoclonal Antibody Market by Type
9.5.5.1.2 Brazil Anti-PCSK9 Monoclonal Antibody Market by Application
9.5.5.2 Argentina Anti-PCSK9 Monoclonal Antibody Market
9.5.5.2.1 Argentina Anti-PCSK9 Monoclonal Antibody Market by Type
9.5.5.2.2 Argentina Anti-PCSK9 Monoclonal Antibody Market by Application
9.5.5.3 Rest of South and Central America Anti-PCSK9 Monoclonal Antibody Market
9.5.5.3.1 Rest of South and Central America Anti-PCSK9 Monoclonal Antibody Market by Type
9.5.5.3.2 Rest of South and Central America Anti-PCSK9 Monoclonal Antibody Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ANTI-PCSK9 MONOCLONAL ANTIBODY MARKET, KEY COMPANY PROFILES
11.1. SANOFI + REGENERON
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AMGEN
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CREATIVE DIAGNOSTICS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. THERMO FISHER SCIENTIFIC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ABNOVA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. DR. REDDY'S
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. GENETEX
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. NOVARTIS AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PERKINELMER
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1.Sanofi + Regeneron
2.Amgen
3.Creative Diagnostics
4.Thermo Fisher Scientific
5.Abnova
6.Dr. Reddy's
7.Merck
8.GeneTex
9.Novartis AG
10.PerkinElmer
TIPRE00023268
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking